what is the most performance mid cap stock between january 2 2019 and march 30 2019

Axsome Therapeutics (AXSM) had the highest return between January 2, 2019 and March 30, 2019 by a mid-cap US stock, returning 406.4%.

ASSET DATE % RETURN
Axsome Therapeutics (AXSM)
1/2/2019 - 3/30/2019
406.41%
Catalyst Pharmaceuticals (CPRX)
1/2/2019 - 3/30/2019
168.42%
StoneCo  (STNE)
1/2/2019 - 3/30/2019
124.77%
Riot Blockchain (RIOT)
1/2/2019 - 3/30/2019
116.56%
Guardant Health (GH)
1/2/2019 - 3/30/2019
106.4%
YETI (YETI)
1/2/2019 - 3/30/2019
105.36%
Veracyte (VCYT)
1/2/2019 - 3/30/2019
104.91%
Enphase Energy (ENPH)
1/2/2019 - 3/30/2019
99.35%
TG Therapeutics (TGTX)
1/2/2019 - 3/30/2019
99.01%
Ascendis Pharma A-S (ASND)
1/2/2019 - 3/30/2019
90.36%
Protagonist Therapeutics (PTGX)
1/2/2019 - 3/30/2019
90.17%
Griffon (GFF)
1/2/2019 - 3/30/2019
82.1%
TransAlta (TAC)
1/2/2019 - 3/30/2019
80.77%
Boot Barn (BOOT)
1/2/2019 - 3/30/2019
80.17%
Coty (COTY)
1/2/2019 - 3/30/2019
80.03%
CleanSpark (CLSK)
1/2/2019 - 3/30/2019
74%
Lattice Semiconductor (LSCC)
1/2/2019 - 3/30/2019
73.91%
Tandem Diabetes Care (TNDM)
1/2/2019 - 3/30/2019
73.4%
ACADIA Pharmaceuticals (ACAD)
1/2/2019 - 3/30/2019
69.51%
Smartsheet (SMAR)
1/2/2019 - 3/30/2019
68.69%
Wayfair (W)
1/2/2019 - 3/30/2019
68.04%
Universal Display (OLED)
1/2/2019 - 3/30/2019
68%
Ultragenyx (RARE)
1/2/2019 - 3/30/2019
67.5%
New Oriental Education & Technology (EDU)
1/2/2019 - 3/30/2019
67.27%
Magnite (MGNI)
1/2/2019 - 3/30/2019
66.58%
Mid-cap stocks are treated as having a market cap between $2B and $10B.